Clinical Trials By Condition
  1. Dermatomyositis
  2. Mycosis Fungoides
  3. Systemic Lupus Erythematosus
Dermatomyositis
Phase 2, Double-blind, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, and Efficacy of a Non-psychotropic Cannabinoid (JBT-101) in Subjects with Skin Predominant Dermatomyositis

If you are interested in posting your Clinical Trial on the Philadelphia Dermatological Society website, please Click Here to submit a request.